Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care
British Journal of Clinical Pharmacology · 2026
DOI: 10.1002/bcp.70610 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Anne Paulien Langermans und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics, Amsterdam Public Health research institute, Amsterdam University Medical Centre, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Intensive Care Units, Drug-Related Side Effects and Adverse Reactions, Critical Care, Drug Monitoring. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research, ZonMw.
Themen: Medikationssicherheit, Intensivpflege
Abstract (Originalsprache)
Aims
Electronic triggers (e‐triggers) are used as screening signals to detect potential adverse drug events (ADEs) and offer an effective system level approach for medication safety surveillance. Their clinical utility is typically evaluated through time‐consuming manual chart review by experts, limiting implementation. Estimating associations between e‐triggers and relevant ICU patient outcomes may provide a rapid, data‐driven alternative. In this study, electronic supratherapeutic drug concentration triggers (eSDCT) were used as a use case.
Methods
Pseudonymized Electronic Health Record (EHR) data from adults admitted to 14 Dutch ICUs (2010–2020) were analysed. Patients with ≥1 therapeutic drug monitoring measurements were included. eSDCTs were selected based on literature, data availability and expert input. Associations with ICU Length of Stay (LOS), ICU mortality and hospital mortality were assessed using adjusted linear and logistic mixed‐effects models.
Results
Among 6006 ICU admissions, 49.5% ( n = 2973) had ≥1 of the five selected group‐level eSDCTs. Exposed admissions showed higher hospital mortality (38.2% vs . 27.9%), ICU mortality (30.6% vs . 20.3%) and longer ICU LOS (median 13.8 [IQR 5.6–28.1] vs . 7.5 [3.2–15.7] days) compared with unexposed admissions. After adjustment, antibiotic and immunosuppressive eSDCTs remained associated with increased ICU mortality (OR 1.47 [1.26–1.70] and 2.86 [1.56–5.24]), hospital mortality (OR 1.46 [1.27–1.68] and 1.81 [1.07–3.10]) and prolonged ICU LOS (expB 1.82 [1.71–1.94] and 2.99 [2.46–3.62]).
Conclusion
Our data‐driven approach shows that antibiotic and immunosuppressive eSDCTs are associated with worse ICU patient outcomes, supporting their implementation for ICU‐level medication safety surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Informatics, Amsterdam Public Health research institute, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
- ChipSoft, Amsterdam, The Netherlands.
- Department of Intensive Care and Dutch Poison Information Centre, University Medical Centre Utrecht, Utrecht, The Netherlands.
ORCID-Profile: Anne Paulien Langermans, Joanna E Klopotowska
Förderung
- Health Research
- ZonMw
Zitieren
APA
Langermans, A. P., Yasrebi-de Kom, I. A. R., de Lange, D. W., de Keizer, N. F., Klopotowska, J. E., & RESCUE Study group (2026). Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70610
Vancouver
Langermans AP, Yasrebi-de Kom IAR, de Lange DW, de Keizer NF, Klopotowska JE, RESCUE Study group. Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70610
BibTeX
@article{Langermans2026,
author = {Langermans, Anne Paulien and Yasrebi-de Kom, Izak A R and de Lange, Dylan Wayne and de Keizer, Nicolette Fransisca and Klopotowska, Joanna E and RESCUE Study group, RESCUE Study group},
title = {Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70610}
}
EUVIMED